S 2535
115th Congress
Senate
Crime and Law Enforcement
Administrative law and regulatory procedures
Congressional oversight
Department of Justice
Drug trafficking and controlled substances
Drug, alcohol, tobacco use
Health information and medical records
Opioid Quota Reform Act
Introduced: March 12, 2018
Introduced by:
Durbin, Richard J.
Democratic
· Illinois
See on congress.gov
Everywhere this bill has been
5 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 19, 2018
Placed on Senate Legislative Calendar under General Orders. Calendar No. 473.
Jun 19, 2018
Committee on the Judiciary. Reported by Senator Grassley with an amendment in the nature of a substitute. Without written report.
May 24, 2018
Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.
Mar 12, 2018
Read twice and referred to the Committee on the Judiciary. (text of measure as introduced: CR S1632)
Mar 12, 2018
Introduced in Senate
Plain-English summary
Opioid Quota Reform Act
This bill amends the Controlled Substances Act to require the Drug Enforcement Administration (DEA) to consider additional factors—the impact on overall public health and rates of diversion, abuse, and overdose deaths—in setting and adjusting production and manufacturing quotas for fentanyl, oxycodone, hydrocodone, oxymorphone, and hydromorphone.
Additionally, if the DEA increases the production quota of fentanyl, oxycodone, hydrocodone, oxymorphone, or hydromorphone, then it must explain why the public health benefits of increasing the quota outweigh the consequences of potential diversion.
What's happening now
Placed on Senate Legislative Calendar under General Orders. Calendar No. 473.
Committees of jurisdiction
1